The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A 20-year comparison of definitive chemoradiation with 5-FU versus capecitabine in anal cancer patients treated at a single institution.
 
Yoanna S Pumpalova
No Relationships to Disclose
 
Margaret M. Kozak
No Relationships to Disclose
 
Rie von Eyben
No Relationships to Disclose
 
Pamela L. Kunz
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - Ipsen; Lexicon
Research Funding - Advanced Accelerator Applications (Inst); Dicerna (Inst); Esanex (Inst); Genentech/Roche (Inst); Incyte (Inst); Ipsen (Inst); Lexicon (Inst); Merck (Inst); Oxigene (Inst)
 
George A. Fisher
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Genentech; Ipsen; Merck; Novartis
Consulting or Advisory Role - Genentech/Roche; ipsen; Merck
Research Funding - Aduro Biotech (Inst); EpicentRx (Inst); Forty seven (Inst); Genentech/Roche (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Daniel Tandel Chang
Stock and Other Ownership Interests - ViewRay
Honoraria - Varian Medical Systems
Research Funding - Varian Medical Systems
 
Sigurdis Haraldsdottir
No Relationships to Disclose